25.11.2019 |
EN |
Official Journal of the European Union |
C 399/49 |
Judgment of the General Court of 19 September 2019 — Unifarco v EUIPO — GD Tecnologie Interdisciplinari Farmaceutiche (TRICOPID)
(Case T-359/18) (1)
(EU trade mark - Opposition proceedings - Application for EU word mark TRICOPID - Earlier national figurative mark TRICODIN - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EU) 2017/1001)
(2019/C 399/58)
Language of the case: Italian
Parties
Applicant: Unifarco SpA (Santa Giustina, Italy) (represented by: A. Perani and J. Graffer, lawyers)
Defendant: European Union Intellectual Property Office (represented by: L. Rampini, acting as Agent)
Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: GD Tecnologie Interdisciplinari Farmaceutiche Srl (Rome, Italy) (represented by: E. Pepe and M. Farinola, lawyers)
Re:
Action brought against the decision of the Fifth Board of Appeal of EUIPO of 13 March 2018 (Case R 2150/2017-5), relating to opposition proceedings between GD Tecnologie Interdisciplinari Farmaceutiche and Unifarco.
Operative part of the judgment
The Court:
1. |
Dismisses the action; |
2. |
Orders Unifarco SpA to pay the costs, including those incurred by GD Tecnologie Interdisciplinari Farmaceutiche Srl before the Board of Appeal of the European Union Intellectual Property Office (EUIPO). |